You are here: Industry Insights > Gardasil 9

News List

Anti-vaccine sentiment causing deaths, subjecting women to cervical cancer, expert says fiercepharma
December 06, 2018
In recent years, the anti-vaccine movement has gained steam and attracted a growing number of headlines. Now, a vaccine expert says the movement is starting to result in its first deaths.
'Unprecedented' demand for Merck's Gardasil drives monster Q3 fiercepharma
November 09, 2018
Merck’s Gardasil has been propelling the pharma giant’s vaccine unit in recent quarters, and that doesn't look like it'll be changing. The company sees more growth
FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old worldpharmanews
October 12, 2018
The U.S. Food and Drug Administration approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 pre
With nod in older adults, Merck drives HPV shot Gardasil 9 into big new market biospectrum
October 09, 2018
With HPV vaccine uptake slow to take off in the U.S. way back when, Merck & Co.'s Gardasil shots missed out on many eligible patients.
9 days for Gardasil 9: China hands out landmark nod with lightning speed fiercepharma
May 02, 2018
That was remarkably fast: Just nine days into its Gardasil 9 review, China's revamped drug regulator handed Merck's HPV vaccine a conditional green light